-
Mashup Score: 17Vincent Rajkumar: from Madras to Minnesota for myeloma - 10 hour(s) ago
Challenging assumptions seems to be in the blood of Vincent Rajkumar. Take his taste in music. Cerebral, temperate, and mild-mannered are the adjectives that spring immediately to mind as he talks fondly about his day-to-day life as Professor of Medicine and Chair of the Myeloma Amyloidosis Dysproteinemia Group at the Mayo Clinic, Rochester, MN, USA. The Lancet automatically assumed that opera, classical, or perhaps jazz would figure heavily as the conversation turned to music. But then he drops the bombshell: “I’m a major Megadeth fan”.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Pulling Back the Curtain: Robert A. Kyle, MD - ASH Clinical News - 10 hour(s) ago
Pulling Back the Curtain: Robert A. Kyle, MD – Multimedia, Sound Bites – ASH Clinical News
Source: www.ashclinicalnews.orgCategories: General Medicine News, Hem/OncsTweet-
Pulling Back the Curtain: Robert A. Kyle, MD @RobertK68033234 [Oct 1, 2019] @ASHClinicalNews https://t.co/JuR4yaAgqb #mmsm https://t.co/2i0ieKPqvM
-
-
Mashup Score: 4Robert A. Kyle, MD: Lessons From a Legend - 10 hour(s) ago
In this issue of Mayo Clinic Proceedings, there are 2 articles authored by a living legend in medicine: Robert A. Kyle, MD.1,2 The scientific contributions of Dr Kyle over a remarkable 60-year career in medicine have no parallel. From his first publication in 19593 to his latest articles in this issue of the Proceedings, Dr Kyle has defined and redefined the epidemiology, diagnosis, risk stratification, prognosis, and management of the entire spectrum of plasma cell disorders. From monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma,4-6 his academic legacy is unmatched.
Source: www.mayoclinicproceedings.orgCategories: General Medicine News, Hem/OncsTweet-
Robert A. Kyle, MD: Lessons From a Legend [Mar 2019] via @VincentRK @MayoProceedings PDF: https://t.co/pnmIhTQpvo #mmsm @RobertK68033234 https://t.co/VjBFJJ9RdT
-
-
Mashup Score: 5#MMSM - Healthcare Social Media Analytics and Transcripts - 1 day(s) ago
Multiple Myeloma, also known as myeloma or plasma cell myeloma, is cancer of the plasma cells – a kind of white blood cell which is present in the bone
Source: www.symplur.comCategories: General Medicine News, Hem/OncsTweet-
Top Influencers of #MMSM 👉 @SocietyofHemOnc @SagarLonialMD @SylvesterCancer @sanamloghavi @majorajay https://t.co/EhfnZfG54w via @symplur
-
-
Mashup Score: 5#MMSM - Healthcare Social Media Analytics and Transcripts - 1 day(s) ago
Multiple Myeloma, also known as myeloma or plasma cell myeloma, is cancer of the plasma cells – a kind of white blood cell which is present in the bone
Source: www.symplur.comCategories: General Medicine News, Hem/OncsTweet-
Top Influencers of #MMSM 👉 @SocietyofHemOnc @SagarLonialMD @SylvesterCancer @sanamloghavi @majorajay https://t.co/EhfnZfG54w via @symplur
-
-
Mashup Score: 0
A tenth of patients die within 60 days of diagnosis of MM. Infection and renal failure are the main direct causes of early mortality, which cannot be accurately predicted by presenting prognostic features. All patients should be considered at high risk of death during induction therapy.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
Myeloma patients may get infections early (induction; [2005] Augustson et al. @JCO_ASCO https://t.co/g8N8VkmuKT) or later (Lim et al. [2021] CLML https://t.co/CDl33P6aQG) #mmsm #IDonc
-
-
Mashup Score: 4Multiple Myeloma | NEJM - 1 day(s) ago
Multiple myeloma, a plasma-cell neoplasm characterized by skeletal destruction, renal failure, anemia, and hypercalcemia, remains incurable. However, recent advances in its treatment, in particular…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
Infections are an important cause of morbidity & leading cause of death in myeloma [Oct 28, 2004] @RobertK68033234 & @VincentRK @NEJM https://t.co/D8cFdRX3nV #mmsm #IDonc
-
-
Mashup Score: 0
Pneumococcal vaccination: the response of patients with multiple myeloma
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
Lazarus et al. 1980 @amjmed https://t.co/2jdVrSNCt5 #mmsm #IDonc ~30% signif Ab response to immunization (14-valent pneumococcal) - low cost, low risk "...may be prudent medical practice to vaccinate patients with myeloma."
-
-
Mashup Score: 3Home - 2 day(s) ago
Thank you for supporting the ASH Foundation. Your generosity enables the Foundation to provide critical support to the field of hematology through programs in resea rch, career development, and quality care and education. Learn more about the ASH Foundation. ASH is a 501(c)(3) charitable and educational organization. Your contribution is tax-deductible to the extent allowable by law. * The minimum contribution amount is $1. My gift is made in honor (or in memory) of someone. ASH will recognize your
Source: donate.hematology.orgCategories: General Medicine News, Hem/OncsTweet-
ASH is a 501(c)(3) charitable & educational organization. Your contribution is tax-deductible https://t.co/7pT2kGvyEx @ASH_hematology #ASH24
-
-
Mashup Score: 2Online Patient Communities for the E-Patient: “Betwixt and Between” a New Patient and an Expert - 2 day(s) ago
In my first ASCO Connection blog post (10/25/11), I talked about “Participatory Medicine in Oncology” by asking: “What does a healthy medicine and oncology “ecosystem” look like?” I suggested that the
Source: connection.asco.orgCategories: General Medicine News, Hem/OncsTweet-
"So, one thing that sprang out of this discussion was to start a Twitter discussion group on multiple myeloma potentially using the #mmsm flag suggested by Matthew Katz, MD (@subatomicdoc)..." [8/29/13] #ASCOconnection https://t.co/IxinXTKEQD cc @VincentRK @myelomaMD @nsc_natalie https://t.co/IsabYozs9r
-
A #mmsm classic -> Vincent Rajkumar (@VincentRK): from Madras to Minnesota for myeloma - @TheLancet https://t.co/0ZwL82cBdU #ASH24